According to the American Cancer Society, approximately 1 in 8 men in the U.S. will be diagnosed with prostate cancer during ...

New kids on the block: MRI guided transrectal focused US, TULSA, focal laser ablation, histotripsy - a comprehensive review. March 28, 2025 Enzalutamide in patients with high-risk biochemically ...

Dr. Naveen M N discusses significant prostate health issues: benign prostatic hyperplasia (BPH), prostatitis, prostate stones ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for trofolastat (RoTecPSMA), a prostate-specific membrane antigen (PSMA)-targeting agent for detecting ...

Prostate cancer (PCa) management poses challenges due to treatment-related morbidities associated with conventional therapies. Focal therapy (FT) is emerging as a promising alternative for ...

Feb. 3, 2025 — The incidence of advanced prostate cancer in California rose markedly in the decade since doctors stopped routinely screening all men for the disease, according to a new ...

Researchers are warning that men who regularly dodge prostate cancer screening appointments are 45% more likely to die from the disease. Prostate cancer is the most common cancer among men and the ...

However, prostate cancer eventually becomes resistant ... The team's findings suggest a promising approach that could block the harmful switch without the severe side effects typically associated ...

Discover how heated lidocaine gel with periprostatic nerve block shows promise in reducing pain during prostate biopsy.